RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma Article

Chinnaiyan, Prakash, Won, Minhee, Wen, Patrick Y et al. (2013). RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 86(5), 880-884. 10.1016/j.ijrobp.2013.04.036

Open Access International Collaboration

cited authors

  • Chinnaiyan, Prakash; Won, Minhee; Wen, Patrick Y; Rojiani, Amyn M; Wendland, Merideth; Dipetrillo, Thomas A; Corn, Benjamin W; Mehta, Minesh P

sustainable development goals

authors

publication date

  • August 1, 2013

published in

keywords

  • CANCER
  • CARCINOMA
  • EFFICACY
  • GLIOMAS
  • INHIBITION
  • Life Sciences & Biomedicine
  • MAMMALIAN TARGET
  • MULTIFORME
  • Oncology
  • PATHWAY
  • RAPAMYCIN
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology
  • TRIAL

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 880

end page

  • 884

volume

  • 86

issue

  • 5